Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Tucker EW, Guglieri-Lopez B, Ordonez AA, Ritchie B, Klunk MH, Sharma R, Chang YS, Sanchez-Bautista J, Frey S, Lodge MA, Rowe SP, Holt DP, Gobburu JVS, Peloquin CA, Mathews WB, Dannals RF, Pardo CA, Kannan S, Ivaturi VD, Jain SK.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau0965. doi: 10.1126/scitranslmed.aau0965.

PMID:
30518610
2.

Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP.

Mol Imaging Biol. 2018 Nov 7. doi: 10.1007/s11307-018-1293-9. [Epub ahead of print]

PMID:
30406512
3.

Dynamic whole-body PET imaging: principles, potentials and applications.

Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, Cho S, Zaidi H, Casey ME, Wahl RL.

Eur J Nucl Med Mol Imaging. 2018 Sep 29. doi: 10.1007/s00259-018-4153-6. [Epub ahead of print] Review.

PMID:
30269154
4.

Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.

Lodge MA, Leal JP, Rahmim A, Sunderland JJ, Frey EC.

J Nucl Med. 2018 Nov;59(11):1768-1775. doi: 10.2967/jnumed.118.209593. Epub 2018 Jun 14.

PMID:
29903932
5.

Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.

Foss CA, Plyku D, Ordonez AA, Sanchez-Bautista J, Rosenthal HB, Minn I, Lodge MA, Pomper MG, Sgouros G, Jain SK.

J Nucl Med. 2018 Nov;59(11):1751-1756. doi: 10.2967/jnumed.117.207431. Epub 2018 Apr 26.

PMID:
29700124
6.

Feasibility of state of the art PET/CT systems performance harmonisation.

Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, Boellaard R.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1344-1361. doi: 10.1007/s00259-018-3977-4. Epub 2018 Mar 2.

7.

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998. doi: 10.1007/s00259-018-3939-x. Epub 2018 Feb 19.

8.

Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Abraham MR.

J Nucl Cardiol. 2018 Feb 8. doi: 10.1007/s12350-018-1228-5. [Epub ahead of print]

PMID:
29423907
9.

Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.

Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M.

J Nucl Cardiol. 2018 Jan 22. doi: 10.1007/s12350-017-1155-x. [Epub ahead of print] Erratum in: J Nucl Cardiol. 2018 Feb 8;:.

PMID:
29359273
10.

Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.

Byrd D, Christopfel R, Arabasz G, Catana C, Karp J, Lodge MA, Laymon C, Moros EG, Budzevich M, Nehmeh S, Scheuermann J, Sunderland J, Zhang J, Kinahan P.

J Med Imaging (Bellingham). 2018 Jan;5(1):011016. doi: 10.1117/1.JMI.5.1.011016. Epub 2018 Jan 4.

PMID:
29322068
11.

Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.

Mhlanga JC, Chirindel A, Lodge MA, Wahl RL, Subramaniam RM.

Nucl Med Commun. 2018 Feb;39(2):154-160. doi: 10.1097/MNM.0000000000000786.

PMID:
29227348
12.

Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom.

Mansor S, Pfaehler E, Heijtel D, Lodge MA, Boellaard R, Yaqub M.

Med Phys. 2017 Dec;44(12):6413-6424. doi: 10.1002/mp.12623. Epub 2017 Nov 19.

13.

ACR-SPR-STR Practice Parameter for the Performance of Cardiac Positron Emission Tomography - Computed Tomography (PET/CT) Imaging.

Subramaniam RM, Janowitz WR, Johnson GB, Lodge MA, Parisi MT, Ferguson MR, Hellinger JC, Gladish GW, Gupta NK.

Clin Nucl Med. 2017 Dec;42(12):918-927. doi: 10.1097/RLU.0000000000001827.

PMID:
28922191
14.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D.

Neuro Oncol. 2017 Jun 1;19(6):845-852. doi: 10.1093/neuonc/nox020.

15.

The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study.

Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA.

J Neurooncol. 2017 May;132(3):513-519. doi: 10.1007/s11060-017-2404-1. Epub 2017 Mar 17.

PMID:
28315063
16.

Enhancing ejection fraction measurement through 4D respiratory motion compensation in cardiac PET imaging.

Tang J, Wang X, Gao X, Segars WP, Lodge MA, Rahmim A.

Phys Med Biol. 2017 Jun 7;62(11):4496-4513. doi: 10.1088/1361-6560/aa6417. Epub 2017 Mar 2.

PMID:
28252451
17.

Repeatability of SUV in Oncologic 18F-FDG PET.

Lodge MA.

J Nucl Med. 2017 Apr;58(4):523-532. doi: 10.2967/jnumed.116.186353. Epub 2017 Feb 23. Review.

18.

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.

Pili R, Liu G, Chintala S, Verheul H, Rehman S, Attwood K, Lodge MA, Wahl R, Martin JI, Miles KM, Paesante S, Adelaiye R, Godoy A, King S, Zwiebel J, Carducci MA.

Br J Cancer. 2017 Mar 28;116(7):874-883. doi: 10.1038/bjc.2017.33. Epub 2017 Feb 21.

19.

Simplifying volumes-of-interest (VOIs) definition in quantitative SPECT: Beyond manual definition of 3D whole-organ VOIs.

Vicente EM, Lodge MA, Rowe SP, Wahl RL, Frey EC.

Med Phys. 2017 May;44(5):1707-1717. doi: 10.1002/mp.12164. Epub 2017 Mar 28.

20.

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.

Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL.

EJNMMI Res. 2017 Dec;7(1):8. doi: 10.1186/s13550-017-0258-3. Epub 2017 Jan 19.

21.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.

Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG.

J Nucl Med. 2017 Jun;58(6):942-946. doi: 10.2967/jnumed.116.179739. Epub 2016 Dec 8.

22.

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer.

Yue J, Mauxion T, Reyes DK, Lodge MA, Hobbs RF, Rong X, Dong Y, Herman JM, Wahl RL, Geschwind JH, Frey EC.

Med Phys. 2016 Oct;43(10):5779.

23.

Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.

Lodge MA, Holdhoff M, Leal JP, Bag AK, Nabors LB, Mintz A, Lesser GJ, Mankoff DA, Desai AS, Mountz JM, Lieberman FS, Fisher JD, Desideri S, Ye X, Grossman SA, Schiff D, Wahl RL.

J Nucl Med. 2017 Mar;58(3):393-398. doi: 10.2967/jnumed.116.178434. Epub 2016 Sep 29.

24.

Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction.

Karakatsanis NA, Casey ME, Lodge MA, Rahmim A, Zaidi H.

Phys Med Biol. 2016 Aug 7;61(15):5456-85. doi: 10.1088/0031-9155/61/15/5456. Epub 2016 Jul 6.

25.

Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.

O JH, Lodge MA, Wahl RL.

Radiology. 2016 Aug;280(2):576-84. doi: 10.1148/radiol.2016142043. Epub 2016 Feb 24. Review.

26.

Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.

Sheikhbahaei S, Marcus C, Wray R, Rahmim A, Lodge MA, Subramaniam RM.

Nucl Med Commun. 2016 Mar;37(3):288-96. doi: 10.1097/MNM.0000000000000445.

PMID:
26650959
27.

ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.

Frey KA, Lodge MA, Meltzer CC, Peller PJ, Wong TZ, Hess CP, Petrella JR, Sair HI, Subramaniam RM.

Clin Nucl Med. 2016 Feb;41(2):118-25. doi: 10.1097/RLU.0000000000001037.

PMID:
26646994
28.

Image-derived and arterial blood sampled input functions for quantitative PET imaging of the angiotensin II subtype 1 receptor in the kidney.

Feng T, Tsui BM, Li X, Vranesic M, Lodge MA, Gulaldi NC, Szabo Z.

Med Phys. 2015 Nov;42(11):6736-44. doi: 10.1118/1.4934375.

29.

Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Karakatsanis NA, Zhou Y, Lodge MA, Casey ME, Wahl RL, Zaidi H, Rahmim A.

Phys Med Biol. 2015 Nov 21;60(22):8643-73. doi: 10.1088/0031-9155/60/22/8643. Epub 2015 Oct 28.

30.

Quantitative myocardial perfusion PET parametric imaging at the voxel-level.

Mohy-Ud-Din H, Lodge MA, Rahmim A.

Phys Med Biol. 2015 Aug 7;60(15):6013-37. doi: 10.1088/0031-9155/60/15/6013. Epub 2015 Jul 28.

PMID:
26216052
31.

¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.

Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY.

J Nucl Med. 2015 Jul;56(7):1003-1010. doi: 10.2967/jnumed.115.154336. Epub 2015 Jun 11.

32.

Performance assessment of a NaI(Tl) gamma counter for PET applications with methods for improved quantitative accuracy and greater standardization.

Lodge MA, Holt DP, Kinahan PE, Wong DF, Wahl RL.

EJNMMI Phys. 2015 May;2. pii: 11. doi: 10.1186/s40658-015-0114-3.

33.

Repeatability of Radiotracer Uptake in Normal Abdominal Organs with ¹¹¹In-Pentetreotide Quantitative SPECT/CT.

Rowe SP, Vicente E, Anizan N, Wang H, Leal JP, Lodge MA, Frey EC, Wahl RL.

J Nucl Med. 2015 Jul;56(7):985-8. doi: 10.2967/jnumed.115.155358. Epub 2015 May 14.

34.

Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.

Antoniou AJ, Raja S, El-Khouli R, Mena E, Lodge MA, Wahl RL, Clarke JO, Pasricha P, Ziessman HA.

J Nucl Med. 2015 May;56(5):721-7. doi: 10.2967/jnumed.114.152074. Epub 2015 Mar 12.

35.

Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time.

Chirindel A, Alluri KC, Tahari AK, Chaudhry M, Wahl RL, Lodge MA, Subramaniam RM.

Clin Nucl Med. 2015 Jan;40(1):e17-22. doi: 10.1097/RLU.0000000000000446.

36.

An Exocrine Pancreatic Stress Test with (11)C-Acetate PET and Secretin Stimulation.

Hyun O J, Lodge MA, Jagannath S, Buscaglia JM, Olagbemiro Y, Wahl RL.

J Nucl Med. 2014 Jul;55(7):1128-31. doi: 10.2967/jnumed.113.135681. Epub 2014 May 19.

37.

Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.

Tahari AK, Lodge MA, Wahl RL.

J Med Imaging Radiat Oncol. 2014;58(3):277-82. doi: 10.1111/1754-9485.12154. Epub 2014 Jan 20.

38.

Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation.

Karakatsanis NA, Lodge MA, Zhou Y, Wahl RL, Rahmim A.

Phys Med Biol. 2013 Oct 21;58(20):7419-45. doi: 10.1088/0031-9155/58/20/7419. Epub 2013 Sep 30.

39.

Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application.

Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A.

Phys Med Biol. 2013 Oct 21;58(20):7391-418. doi: 10.1088/0031-9155/58/20/7391. Epub 2013 Sep 30.

40.

Absolute myocardial flow quantification with (82)Rb PET/CT: comparison of different software packages and methods.

Tahari AK, Lee A, Rajaram M, Fukushima K, Lodge MA, Lee BC, Ficaro EP, Nekolla S, Klein R, deKemp RA, Wahl RL, Bengel FM, Bravo PE.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):126-35. doi: 10.1007/s00259-013-2537-1. Epub 2013 Aug 28.

41.

Cardiac PET/CT misregistration causes significant changes in estimated myocardial blood flow.

Rajaram M, Tahari AK, Lee AH, Lodge MA, Tsui B, Nekolla S, Wahl RL, Bengel FM, Bravo PE.

J Nucl Med. 2013 Jan;54(1):50-4. doi: 10.2967/jnumed.112.108183. Epub 2012 Oct 22.

42.

Noise considerations for PET quantification using maximum and peak standardized uptake value.

Lodge MA, Chaudhry MA, Wahl RL.

J Nucl Med. 2012 Jul;53(7):1041-7. doi: 10.2967/jnumed.111.101733. Epub 2012 May 24.

43.

Effect of patient arm motion in whole-body PET/CT.

Lodge MA, Mhlanga JC, Cho SY, Wahl RL.

J Nucl Med. 2011 Dec;52(12):1891-7. doi: 10.2967/jnumed.111.093583. Epub 2011 Nov 11.

44.

Radiation dosimetry of 82Rb in humans under pharmacologic stress.

Senthamizhchelvan S, Bravo PE, Lodge MA, Merrill J, Bengel FM, Sgouros G.

J Nucl Med. 2011 Mar;52(3):485-91. doi: 10.2967/jnumed.110.083477. Epub 2011 Feb 14.

45.

Characterization of a perirectal artifact in 18F-FDG PET/CT.

Lodge MA, Chaudhry MA, Udall DN, Wahl RL.

J Nucl Med. 2010 Oct;51(10):1501-6. doi: 10.2967/jnumed.110.079145. Epub 2010 Sep 16.

46.

Human biodistribution and radiation dosimetry of 82Rb.

Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM.

J Nucl Med. 2010 Oct;51(10):1592-9. doi: 10.2967/jnumed.110.077669. Epub 2010 Sep 16.

47.

Pre-clinical myocardial metabolic alterations in chronic kidney disease.

Fink JC, Lodge MA, Smith MF, Hinduja A, Brown J, Dinits-Pensy MY, Dilsizian V.

Cardiology. 2010;116(3):160-7. doi: 10.1159/000318227. Epub 2010 Jul 7.

48.

Simultaneous measurement of noise and spatial resolution in PET phantom images.

Lodge MA, Rahmim A, Wahl RL.

Phys Med Biol. 2010 Feb 21;55(4):1069-81. doi: 10.1088/0031-9155/55/4/011. Epub 2010 Jan 28.

49.

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison.

Hobbs RF, Wahl RL, Lodge MA, Javadi MS, Cho SY, Chien DT, Ewertz ME, Esaias CE, Ladenson PW, Sgouros G.

J Nucl Med. 2009 Nov;50(11):1844-7. doi: 10.2967/jnumed.109.066738. Epub 2009 Oct 16.

50.

A practical, automated quality assurance method for measuring spatial resolution in PET.

Lodge MA, Rahmim A, Wahl RL.

J Nucl Med. 2009 Aug;50(8):1307-14. doi: 10.2967/jnumed.108.060079. Epub 2009 Jul 17.

Supplemental Content

Loading ...
Support Center